Market Cap 1.16B
Revenue (ttm) 731.97M
Net Income (ttm) 159.52M
EPS (ttm) N/A
PE Ratio 7.77
Forward PE 8.70
Profit Margin 21.79%
Debt to Equity Ratio 0.80
Volume 409,000
Avg Vol 542,508
Day's Range N/A - N/A
Shares Out 47.14M
Stochastic %K 7%
Beta 0.77
Analysts Sell
Price Target $32.40

Company Profile

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin to prevent and treat deep vein thrombosis; REXTOVY and Naloxon...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 909 980 9484
Address:
11570 6th Street, Rancho Cucamonga, United States
EquityInvest
EquityInvest Jun. 20 at 3:33 PM
$AMPH they just got another CRL! 🤣🤣🤣
0 · Reply
Estimize
Estimize May. 13 at 8:00 PM
Wall St is expecting 0.74 EPS for $AMPH Q2 [Reporting 08/11 AMC] http://www.estimize.com/intro/amph?chart=historical&metric_name=eps&utm_co
0 · Reply
JarvisFlow
JarvisFlow May. 12 at 12:30 PM
JP Morgan has adjusted their stance on Amphastar Pharma ( $AMPH ), setting the rating to Neutral with a target price of 45 → 30.
0 · Reply
EquityInvest
EquityInvest May. 9 at 5:33 PM
$AMPH 🤣😂
0 · Reply
JarvisFlow
JarvisFlow May. 8 at 1:22 PM
Wells Fargo has adjusted their stance on Amphastar Pharma ( $AMPH ), setting the rating to Overweight with a target price of 40 → 35.
0 · Reply
EquityInvest
EquityInvest May. 5 at 3:59 PM
$AMPH is it true that their Chinese plant makes fentanyl?
0 · Reply
EquityInvest
EquityInvest May. 5 at 5:10 AM
$XERS gotta love the prospects for this company, especially when they have such a weak competition like $AMPH. If I have to be on one then no question that $XERS will win. A year from now it will have a higher market cap just wait ha ha
0 · Reply
EquityInvest
EquityInvest May. 5 at 5:06 AM
$AMPH adding to my short and getting ready for another terrible earnings report this week. At this point, they have no choice but to discuss all of their CRL‘s and FDA rejections. Real no future for them trying to switch to brands good luck ha ha they don’t know how to sell brands have you hear of jumping the shark??? 😂
0 · Reply
swingingtech
swingingtech Apr. 23 at 5:59 PM
$AMPH $SMCI $ENPH $SEDG https://wallstreetwaves.com/midweek-etf-highlights-spxl-and-icln-on-the-move/
0 · Reply
EquityInvest
EquityInvest Apr. 15 at 5:53 PM
$AMPH timber!!!!
0 · Reply
Latest News on AMPH
Amphastar Pharmaceuticals: Navigating Through An Inflection Year

May 11, 2025, 11:32 AM EDT - 6 weeks ago

Amphastar Pharmaceuticals: Navigating Through An Inflection Year


Top 2 Health Care Stocks That May Rocket Higher This Month

Feb 21, 2025, 2:17 PM EST - 4 months ago

Top 2 Health Care Stocks That May Rocket Higher This Month

WST


Amphastar Pharmaceuticals: A Gradual Strategy

Feb 19, 2025, 1:09 PM EST - 4 months ago

Amphastar Pharmaceuticals: A Gradual Strategy


Amphastar Pharmaceuticals: Cheap With Caveats

Jan 3, 2025, 12:48 PM EST - 6 months ago

Amphastar Pharmaceuticals: Cheap With Caveats


Amphastar Pharmaceuticals Inc (AMPH) Trading Down 3.54% on Oct 2

Oct 2, 2024, 12:08 PM EDT - 9 months ago

Amphastar Pharmaceuticals Inc (AMPH) Trading Down 3.54% on Oct 2


6 Beaten Down Stocks Rated Buy (SA Quant)

Aug 19, 2024, 5:00 AM EDT - 11 months ago

6 Beaten Down Stocks Rated Buy (SA Quant)

CAAP CCL STRL TCOM TWLO


Amphastar Pharmaceuticals: Buy When Fear Is Overblown

May 30, 2024, 2:06 AM EDT - 1 year ago

Amphastar Pharmaceuticals: Buy When Fear Is Overblown


EquityInvest
EquityInvest Jun. 20 at 3:33 PM
$AMPH they just got another CRL! 🤣🤣🤣
0 · Reply
Estimize
Estimize May. 13 at 8:00 PM
Wall St is expecting 0.74 EPS for $AMPH Q2 [Reporting 08/11 AMC] http://www.estimize.com/intro/amph?chart=historical&metric_name=eps&utm_co
0 · Reply
JarvisFlow
JarvisFlow May. 12 at 12:30 PM
JP Morgan has adjusted their stance on Amphastar Pharma ( $AMPH ), setting the rating to Neutral with a target price of 45 → 30.
0 · Reply
EquityInvest
EquityInvest May. 9 at 5:33 PM
$AMPH 🤣😂
0 · Reply
JarvisFlow
JarvisFlow May. 8 at 1:22 PM
Wells Fargo has adjusted their stance on Amphastar Pharma ( $AMPH ), setting the rating to Overweight with a target price of 40 → 35.
0 · Reply
EquityInvest
EquityInvest May. 5 at 3:59 PM
$AMPH is it true that their Chinese plant makes fentanyl?
0 · Reply
EquityInvest
EquityInvest May. 5 at 5:10 AM
$XERS gotta love the prospects for this company, especially when they have such a weak competition like $AMPH. If I have to be on one then no question that $XERS will win. A year from now it will have a higher market cap just wait ha ha
0 · Reply
EquityInvest
EquityInvest May. 5 at 5:06 AM
$AMPH adding to my short and getting ready for another terrible earnings report this week. At this point, they have no choice but to discuss all of their CRL‘s and FDA rejections. Real no future for them trying to switch to brands good luck ha ha they don’t know how to sell brands have you hear of jumping the shark??? 😂
0 · Reply
swingingtech
swingingtech Apr. 23 at 5:59 PM
$AMPH $SMCI $ENPH $SEDG https://wallstreetwaves.com/midweek-etf-highlights-spxl-and-icln-on-the-move/
0 · Reply
EquityInvest
EquityInvest Apr. 15 at 5:53 PM
$AMPH timber!!!!
0 · Reply
clan
clan Apr. 11 at 1:36 PM
$MNKD Unquestionable progress and positive outlook. ↗️ MNKD is going up from here ... for a long time. $UTHR partner. $CIPLA.NSE partner. $AMPH partner.
0 · Reply
EquityInvest
EquityInvest Apr. 10 at 2:18 PM
$AMPH strike 25 puts 6X return!!
0 · Reply
JarvisFlow
JarvisFlow Apr. 10 at 11:30 AM
Needham has updated their rating for Amphastar Pharma ( $AMPH ) to Hold.
0 · Reply
EquityInvest
EquityInvest Apr. 10 at 2:09 AM
$AMPH Dan dischner is either an idiot or a liar or both two CRLs and he says they will get 2 to 3 approvals this year shows he knows nothing about FDA process. This company is a $10 company at best. Total amateur hour. Lucky to have the products they do but nothing new in a long time and the one big purchase they did as a joke. The big guys already are looking at things that are gonna make that medicine useless. All my other Pharma shorts have played themselves out, but this is the one that went up only to allow for more money to be made.
0 · Reply
EquityInvest
EquityInvest Apr. 3 at 5:58 PM
$VXRT $IGMS $VXRT $AMPH $SLRN go back to all my posts on these companies over the last few years and see the returns that I am talking about shorting. These are companies that all could and should go bankrupt. Click to subscribe!
0 · Reply
EquityInvest
EquityInvest Apr. 3 at 5:57 PM
$VXRT so much money made in the last two years on all my short pics, including $AMPH. My only regret is covering too soon we’re not shorting enough!
0 · Reply
EquityInvest
EquityInvest Apr. 3 at 5:47 PM
$SLRN another example of a company founded by a Chinese scientist, who has no clue about business impossible links to government. Same with $AMPH in the long run these companies will fail or be bought at pennies on the dollar
0 · Reply
EquityInvest
EquityInvest Apr. 3 at 5:36 PM
$AMPH founders should move back to China! 😛
0 · Reply
EquityInvest
EquityInvest Apr. 2 at 7:04 PM
$AMPH CRL just received!! 😛
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 22 at 7:01 AM
$AMPH Digging AMPH's strategic moves. Insulin expansion looks promising. Strong R&D pipeline with 4 key product candidates in 2025. Watching how BAQSIMI partnership plays out. Might add to my pharma watchlist. Potential long-term growth play. interesting article: https://beyondspx.com/article/amphastar-pharmaceuticals-inc-nasdaq-amph-a-diversified-pharmaceutical-powerhouse-navigating-dynamic-markets
1 · Reply
EquityInvest
EquityInvest Mar. 21 at 9:41 PM
Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid - Business Wire $XERS $AMPH https://stocks.apple.com/AR2hl8C0iSH22HPd-fcbnhg
0 · Reply
EquityInvest
EquityInvest Mar. 21 at 8:17 PM
$XERS very clear who is the winner and who is the loser!!! $AMPH
0 · Reply